跳至主要内容
临床试验/CTRI/2025/01/079799
CTRI/2025/01/079799尚未招募不适用

Randomized controlled trial to evaluate the efficacy of Yavanikhandav Churna in the management of Pandu Vyadhi with special reference to Iron Deficiency Anemia in children.

Sane Guruji Arogya Kendra1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年2月9日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
90
试验地点
1
主要终点
To evaluate the efficacy of Yavanikhandav Churna in the management of Pandu Vyadhi with special reference to Iron Deficiency Anemia in children

研究概览

简要总结

This is a Comparative Clinical Study between the efficacy of Yavanikhandav Churna and Ferrous Ascorbate Syrup in the management of Pandu vyadhi with special refrence to Iron Deficency Anemia in children from age group 1 to 12 years.

Primary Objective is to Comparative between  Yavanikhandav Churna and Ferrous Ascorbate Syrup in children from age group 1 to 12 years for 30 days.

Assesment of signs and symptoms will be done and observation will be drawn from the outcome of the Patient.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
1.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Iron Deficency Anemia Diagnosed patients will be included
  • Patients between Hb 09 to12 gm per dl.
  • Patient between the age group of 1 to 12 years will be taken.
  • Primarily the patients will be selected on the basis of Hb percentages found in laboratory investigations also classical symptoms of Pandu Roga.
  • Patients having any 5 or more than 5 lakashanas of the following will be enrolled in the study Panduta (Pallor) Shrama (Reduced exercise capacity) Gatrasada (Fatigue) Gatrashoola (Bodyache) Shwasa (Breathlessness) Hridyaspandana (Palpitation) Aalasya (Drowsiness) Shiroruja (Headache) Aruchi (Anorexia) Dourbalya (Weakness) Akshikut soth (Eye swelling) Karnashweda(Tinitus).

排除标准

  • Drug Allergy
  • Hb less than 9 mg per dl
  • Systemic Diseases
  • Bleeding Disorder
  • Those who are not willing to participate in trial and not ready to give written consent.

结局指标

主要结局

To evaluate the efficacy of Yavanikhandav Churna in the management of Pandu Vyadhi with special reference to Iron Deficiency Anemia in children

时间窗: Treatment will be given for 30 days.Ferrous ascorbate will be given to one group and yavanikhandav churna will be given to another group. | Followup will be taken on 7th 15th and 30th day. | Assesment will be done by objective and subjective parameters. | Final observation will be recorded after completion of treatment.

次要结局

  • Litrature Study of Pandu in Paediatric age group.(To observe the adverse effect if any)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Nikhil Ramesh Pawar

MAM S Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune

研究点 (1)

Loading locations...

相似试验